bioRxivSynthetic BiologyPreprint
Recombinant expression of Proteorhodopsin and biofilm regulators in Escherichia coli for nanoparticle binding and removal in a wastewater treatment model
Justin Z. Yang, Yvonne Wei, Catherine Yeh, Florence Liou, William C. CheniD, Dylan Lu, Christine CheniD, Justin Pei, Candice LeeiD, Emily Chen, Ashley Lin, Paul Imbrogulio, Katie Chang, A. Liaoyuan HU, Jesse Kao, Kelly Chen, Audrey Tei, Chansie YangiD, Katherine Hsu, Laurent Hsia, Oscar Wallace, Abby Hau, Allen P. LiuiD, William Huang, Stephanie Chang, , Jude C. Clapper
Abstract
The small size of nanoparticles is both an advantage and a problem. Their high surface-area-to-volume ratio enables novel medical, industrial, and commercial applications. However, their small size also allows them to evade conventional filtration during water treatment, posing health risks to humans, plants, and aquatic life. This project aims to remove nanoparticles during wastewater treatment using genetically modified Escherichia coli in two ways: 1) binding citrate-capped nanoparticles with the membrane protein Proteorhodopsin, and 2) trapping nanoparticles using Escherichia coli biofilm produced by overexpressing two regulators: OmpR234 and CsgD. We demonstrate experimentally that Escherichia coli expressing Proteorhodopsin binds to 60 nm citrate-capped silver nanoparticles. We also successfully upregulate biofilm production and show that Escherichia coli biofilms are able to trap 30 nm gold particles. Finally, both Proteorhodopsin and biofilm approaches are able to bind and remove nanoparticles in simulated wastewater treatment tanks. We envision integrating our trapping system in both rural and urban wastewater treatment plants to efficiently capture all nanoparticles before treated water is released into the environment.\n\nFinancial DisclosureThis work was funded by the Taipei American School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.\n\nCompeting InterestsThe authors have declared that no competing interests exist.\n\nEthics StatementN/A\n\nData AvailabilityYes - all data are fully available without restriction. Sequences for the plasmids used in this study are available through the Registry of Standard Biological Parts. Links to raw data are included in Supplementary Information.
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Biological Synthesis of Silver Nanoparticles with Aqueous Extract of Azadirachta indica Leaf and Its Antimicrobial Activity on Uropathogenic MDR and ESBL Producing Escherichia coli.
Payel Das·bioRxiv·Apr 10, 2026
- Copper nanoparticles as modulator of active bacterial population and their physiology in ecosphere
A. Alboloushi, A. Alum, M. Abbaszadegan·bioRxiv·Nov 30, 2021
- Antibacterial activity against Escherichia coli: A proof-of-concept study of colloidally aggregated silver nanoparticles with experimental evidence
Mateen Ur Rehman, Sobia Saeed·bioRxiv·Apr 13, 2026
- Bacterial plasma membrane is the main cellular target of silver nanoparticles in Escherichia coli and Pseudomonas aeruginosa
Olesja M Bondarenko, Mariliis Sihtmäe, … Rimantas Daugelavičius·bioRxiv·May 15, 2018
- Using a Bacterial Protein to Selectively Target Bacterial Biofilms: Treatment of S. epidermidis Biofilms with Targeted Photothermal Gold Nanoparticles
Tanveer Shaikh, Dhanush Lakmal Yapa Amarasekara, … Nicholas C. Fitzkee·Journal of Colloid and Interface SciencePeer-reviewed·Oct 10, 2025
- Inhibitory effect of EGCG-AgNPs and their lysozyme bioconjugates on biofilm formation and cytotoxicity
B. Meesaragandla, S. Hayet, … M. Delcea·bioRxiv·Feb 23, 2022